Case Type: Mergers & Acquisitions

Daseke, Inc. (Nasdaq: DSKE), relating to its proposed sale to TFI International, Inc. Under the terms of the agreement, DSKE shareholders will receive $8.30 in cash per share they own.

Karuna Therapeutics, Inc. (Nasdaq: KRTX), relating to its proposed sale to Bristol Myers Squibb. Under the terms of the agreement, KRTX shareholders will receive $330.00 in cash per share they own.

Summit Materials, Inc. (NYSE: SUM), relating to its sale to Cementos Argos S.A. Under the terms of the agreement, Cementos will receive approximately $1.2 billion in cash and 54.7 million shares of SUM. Cementos will own approximately 31% of the combined company on a fully diluted basis.

PGT Innovations, Inc. (NYSE: PGTI), relating to its proposed sale to Masonite International Corp. Under the terms of the agreement, PGTI shareholders will receive $7.50 in common shares of Masonite and $33.50 in cash per share they own.

United States Steel Corp. (NYSE: X), relating to its proposed sale to Nippon Steel Corp. Under the terms of the agreement, X shareholders are expected to receive $55.00 in cash per share they own.

Gracell Biotechnologies Inc. (Nasdaq: GRCL), relating to its proposed sale to AstraZeneca. Under the terms of the agreement, AstraZeneca will acquire GRCL for $2.00 per share in cash (equal to $10.00 per American Depositary Share of GRCL), plus a non-tradable CVR worth $0.30 per share in cash (equal to $1.50 per ADS of GRCL) payable … Read more

RayzeBio, Inc. (Nasdaq: RYZB), relating to its proposed sale to Bristol-Myers Squibb Co. Under the terms of the agreement, RYZB shareholders are expected to receive $62.50 in cash per share they own.

HollySys Automation Technologies Ltd. (Nasdaq: HOLI), relating to its proposed sale to Ascendant Capital Partners. Under the terms of the agreement, HOLI shareholders will receive $26.50 in cash per share they own.

Eagle Bulk Shipping Inc. (NYSE: EGLE), relating to its proposed merger with Star Bulk Carriers Corp. Under the terms of the agreement, EGLE shareholders will receive 2.6211 shares of Star Bulk per share they own.

Icosavax, Inc. (Nasdaq: ICVX), relating to its proposed sale to AstraZeneca. Under the terms of the agreement, ICVX shareholders are expected to receive $15.00 in cash and one non-tradeable CVR worth up to $5.00 per share they own.